EDGAR Filing Documents for 0001019687-13-003495

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:

SEC Accession No. 0001019687-13-003495

Filing Date

2013-09-09

Accepted

2013-09-09 16:21:23

Documents

Period of Report

2013-07-31

Document Format Files

Seq	Description	Document	Type	Size
1	QUARTERLY REPORT	peregrine_10q-073113.htm	10-Q	504960
2	CERTIFICATION OF CHIEF EXECUTIVE OFFICER	peregrine_ex3101.htm	EX-31.1	7825
3	CERTIFICATION OF CHIEF FINANCIAL OFFICER	peregrine_ex3102.htm	EX-31.2	8033
4	CERTIFICATION	peregrine_ex3200.htm	EX-32	6038
	Complete submission text file	0001019687-13-003495.txt		3609534

Data Files

Seq	Description	Document	Type	Size
5	XBRL INSTANCE FILE	pphm-20130731.xml	EX-101.INS	309457
6	XBRL SCHEMA FILE	pphm-20130731.xsd	EX-101.SCH	25713
7	XBRL CALCULATION FILE	pphm-20130731_cal.xml	EX-101.CAL	43293
8	XBRL DEFINITION FILE	pphm-20130731_def.xml	EX-101.DEF	53497
9	XBRL LABEL FILE	pphm-20130731_lab.xml	EX-101.LAB	200162
10	XBRL PRESENTATION FILE	pphm-20130731_pre.xml	EX-101.PRE	143900

Mailing Address 14282 FRANKLIN AVE TUSTIN CA 92780

Business Address 14282 FRANKLIN AVE TUSTIN CA 92780 7145086000

PEREGRINE PHARMACEUTICALS INC (Filer) CIK: 0000704562 (see all company filings)